Data Insights

By Company Name

By Disease Name

By Drug Name

By Themes

Showing 4 results out of 4

Company Profiles

Access comprehensive reports covering all the major players in the pharmaceutical industry

Gain a competitive edge
Enhance your sales strategy
Get forward-looking insights
Support your decision making

Buy Now

Data Insights

MNV-201 by Minovia Therapeutics for Subacute Necrotizing Encephalomyelopathy (Leigh Disease): Likelihood of Approval

MNV-201 is under clinical development by Minovia Therapeutics and currently in Phase I for Subacute Necrotizing Encephalomyelopathy (Leigh Disease). According...

Data Insights

MNV-201 by Minovia Therapeutics for Pearson Syndrome: Likelihood of Approval

MNV-201 is under clinical development by Minovia Therapeutics and currently in Phase I for Pearson Syndrome. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - MNV-201 in Pearson Syndrome

Data Insights

MNV-201 by Minovia Therapeutics for Subacute Necrotizing Encephalomyelopathy (Leigh Disease): Likelihood of Approval

MNV-201 is under clinical development by Minovia Therapeutics and currently in Phase I for Subacute Necrotizing Encephalomyelopathy (Leigh Disease). According...

Likelihood of Approval and Phase Transition Success Rate Model - MNV-201 in Subacute Necrotizing Encephalomyelopathy (Leigh Disease)

Data Insights

MNV-201 by Minovia Therapeutics for Pearson Syndrome: Likelihood of Approval

MNV-201 is under clinical development by Minovia Therapeutics and currently in Phase I for Pearson Syndrome. According to GlobalData, Phase...

Likelihood of Approval and Phase Transition Success Rate Model - MNV-201 in Pearson Syndrome

Sections

Sections

Sections

Sections

Sections

Company Profiles

MNV-201 by Minovia Therapeutics for Subacute Necrotizing Encephalomyelopathy (Leigh Disease): Likelihood of Approval

MNV-201 by Minovia Therapeutics for Pearson Syndrome: Likelihood of Approval

MNV-201 by Minovia Therapeutics for Subacute Necrotizing Encephalomyelopathy (Leigh Disease): Likelihood of Approval

MNV-201 by Minovia Therapeutics for Pearson Syndrome: Likelihood of Approval